{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:37:59Z","timestamp":1791999479917,"version":"4.4.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:00:00Z","timestamp":1671840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1038\/s41443-022-00658-1","type":"journal-article","created":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T06:03:00Z","timestamp":1671861780000},"page":"223-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The incidence of surgical intervention in veterans treated with Collagenase clostridium histolyticum"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9051-5400","authenticated-orcid":false,"given":"Isaac J.","family":"Zucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirpi","family":"Nackeeran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5211-9271","authenticated-orcid":false,"given":"Thomas A.","family":"Masterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,24]]},"reference":[{"key":"658_CR1","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1464-410X.2006.05969.x","volume":"97","author":"MD Bjekic","year":"2006","unstructured":"Bjekic MD, Vlajinac HD, Sipetic SB, Marinkovic JM. Risk factors for Peyronie\u2019s disease: a case-control study. BJU Int. 2006;97:570\u20134.","journal-title":"BJU Int"},{"key":"658_CR2","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1111\/j.1743-6109.2008.01011.x","volume":"5","author":"M Gelbard","year":"2008","unstructured":"Gelbard M. Myofibroblasts and mechanotransduction: do forces in the tunica albuginea contribute to Peyronie\u2019s disease? J Sex Med. 2008;5:2974\u20136.","journal-title":"J Sex Med"},{"key":"658_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.21037\/tau.2016.05.14","volume":"5","author":"JE Terrier","year":"2016","unstructured":"Terrier JE, Nelson CJ. Psychological aspects of Peyronie\u2019s disease. Transl Androl Urol. 2016;5:290\u20135.","journal-title":"Transl Androl Urol"},{"key":"658_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","volume":"194","author":"A Nehra","year":"2015","unstructured":"Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, et al. Peyronie\u2019s disease: AUA guideline. J Urol. 2015;194:745\u201353.","journal-title":"J Urol"},{"key":"658_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1743-6109.2007.00651.x","volume":"5","author":"GH Jordan","year":"2008","unstructured":"Jordan GH. The use of intralesional clostridial collagenase injection therapy for Peyronie\u2019s disease: a prospective, single-center, non-placebo-controlled study. J Sex Med. 2008;5:180\u20137.","journal-title":"J Sex Med"},{"key":"658_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190:199\u2013207.","journal-title":"J Urol"},{"key":"658_CR7","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/bju.14410","volume":"122","author":"A Cocci","year":"2018","unstructured":"Cocci A, Russo GI, Briganti A, Salonia A, Cacciamani G, Capece M, et al. Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie\u2019s disease: development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study. BJU Int. 2018;122:680\u20137.","journal-title":"BJU Int"},{"key":"658_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.urology.2018.06.003","volume":"119","author":"K Wymer","year":"2018","unstructured":"Wymer K, Ziegelmann M, Savage J, Kohler T, Trost L. Plaque Calcification: an important predictor of collagenase clostridium histolyticum treatment outcomes for men with Peyronie\u2019s disease. Urology 2018;119:109\u201314.","journal-title":"Urology"},{"key":"658_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/JU.0000000000000032","volume":"201","author":"WJG Hellstrom","year":"2019","unstructured":"Hellstrom WJG, Tue Nguyen HM, Alzweri L, Chung A, Virasoro R, Tapscott A, et al. Intralesional collagenase clostridium histolyticum causes meaningful improvement in men with Peyronie\u2019s disease: results of a multi-institutional analysis. J Urol. 2019;201:777\u201382.","journal-title":"J Urol"},{"key":"658_CR10","unstructured":"Affairs USDoV. VA Informatics and Computing Infrastructure (VINCI): Office of research & development. Available from: https:\/\/www.research.va.gov\/programs\/vinci\/default.cfm."},{"key":"658_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/jsm.12721","volume":"12","author":"LA Levine","year":"2015","unstructured":"Levine LA, Larsen SM. Surgical correction of persistent Peyronie\u2019s disease following collagenase clostridium histolyticum treatment. J Sex Med. 2015;12:259\u201364.","journal-title":"J Sex Med"},{"key":"658_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.urology.2017.08.037","volume":"110","author":"K DeLay","year":"2017","unstructured":"DeLay K, Diao L, Nguyen HMT, Zurawin J, Libby R, Yafi F, et al. Successful treatment of residual curvature in peyronie disease in men previously treated with intralesional collagenase clostridium histolyticum. Urology 2017;110:110\u20133.","journal-title":"Urology"},{"key":"658_CR13","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.juro.2015.10.065","volume":"195","author":"MJ Ziegelmann","year":"2016","unstructured":"Ziegelmann MJ, Viers BR, McAlvany KL, Bailey GC, Savage JB, Trost LW. Restoration of penile function and patient satisfaction with intralesional collagenase clostridium histolyticum injection for Peyronie\u02bcs disease. J Urol. 2016;195:1051\u20136.","journal-title":"J Urol"},{"key":"658_CR14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.jsxm.2020.02.002","volume":"17","author":"P Bajic","year":"2020","unstructured":"Bajic P, Wiggins AB, Ziegelmann MJ, Levine LA. Characteristics of men with peyronie\u2019s disease and collagenase clostridium histolyticum treatment failure: predictors of surgical intervention and outcomes. J Sex Med. 2020;17:1005\u201311.","journal-title":"J Sex Med"},{"key":"658_CR15","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.jsxm.2017.08.008","volume":"14","author":"HMT Nguyen","year":"2017","unstructured":"Nguyen HMT, Anaissie J, DeLay KJ, Yafi FA, Sikka SC, Hellstrom WJG. Safety and efficacy of collagenase clostridium histolyticum in the treatment of acute-phase Peyronie\u2019s disease. J Sex Med. 2017;14:1220\u20135.","journal-title":"J Sex Med"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00658-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00658-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00658-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T05:04:14Z","timestamp":1713762254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-022-00658-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,24]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["658"],"URL":"https:\/\/doi.org\/10.1038\/s41443-022-00658-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1795398\/v1","asserted-by":"object"}]},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,24]]},"assertion":[{"value":"25 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}